Retatrutide: selected references HeartPep literature library, reviewed 2026-11-20 https://heartpep.com/us/research/library/retatrutide 1. Jastreboff AM, Kaplan LM, Frías JP, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2301972 PMID: 37366315 Source: https://pubmed.ncbi.nlm.nih.gov/37366315/ Verification: Abstract / bibliographic record. 2. Jastreboff AM, Kaplan LM, Davies MJ, et al.; TRIUMPH-1 Investigators (2026). Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2604169 PMID: 42814954 Source: https://pubmed.ncbi.nlm.nih.gov/42814954/ Verification: Abstract / bibliographic record. 3. Bellido V, le Roux CW, Ekinci EI, et al. (2026). Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial The Lancet. DOI: https://doi.org/10.1016/S0140-6736(26)01861-1 PMID: 42810372 Source: https://pubmed.ncbi.nlm.nih.gov/42810372/ Verification: Abstract / bibliographic record. 4. Schnitzer TJ, Hunter DJ, Conaghan PG, et al. (2026). Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2610676 PMID: 43001755 Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2610676 Verification: Full text. 5. Eli Lilly and Company (sponsor) (2026). TRANSCEND-CKD: retatrutide and renal function (NCT05936151) ClinicalTrials.gov registry results. Source: https://clinicaltrials.gov/study/NCT05936151?tab=results Verification: Abstract / bibliographic record. 6. Grunstein RR et al. (2026). Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea New England Journal of Medicine. DOI: https://doi.org/10.1056/NEJMoa2611477 PMID: 42904878 Source: https://pubmed.ncbi.nlm.nih.gov/42904878/ Verification: Abstract / bibliographic record. These are selected background references, not evidence that a HeartPep product or batch matches a studied preparation. Cite and assess the original papers.